Duchenne muscular dystrophy (DMD) can result in dysfunctional muscle stem cells, which in turn drive DMD pathology.
The remote monitoring of physical exercise among boys with Duchenne muscular dystrophy has been found to be safe and efficacious.
We explore why Duchenne muscular dystrophy is a disease that can benefit tremendously from advances in stem cell research.
Various research institutions are investing time and money to refine gene therapy as a viable treatment technique for patients with DMD.
We investigate the importance of cardiac care in DMD patients and explore how it has improved over the last few years.
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.
Is genome editing ready for widespread use among DMD patients around the globe? We explore this question in detail.
We investigate how CRISPR/Cas technology is contributing to genetic studies and its impact on DMD research.
We still do not have a primary cure for DMD, so what strategies are available for improving patient care?
Researchers investigated the promise and the pitfalls of gene therapy in DMD patient care and explored whether it has a viable future.